MIT Tech Review: How AI is Transforming Drug Development

A Closer Look at MIT Tech Review's Predictions For AI-Led Drug Development. In this roundtable, Holly Leslie will interview our two guests, will discuss the latest findings from MIT Tech Review and offer perspectives on how AI is reshaping the way drugs are brought to market.

Behrooz Najafi
Chief Technology Officer / Chief Information Officer
Holly Leslie
Sr. Director, Life Sciences
Egnyte
Nagaraja Srivatsan
Chief Digital Officer, R&D Technology Solutions
IQVIA
Jason Sparapani
Content Manager, Insights
MIT Tech Review